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Introduction
Proper vascularization of organs and tissues requires not only
angiogenesis and arteriovenous differentiation, but also
appropriate patterning of the vascular network. Emerging
evidence has suggested that the nervous system may play a role
in coordinating these processes (reviewed by Carmeliet, 2003),
but precisely how is unclear. Previously, we have found that in
embryonic limb skin, arteries but not veins are aligned with
peripheral nerves, and their branching pattern follows that of
the nerves (Mukouyama et al., 2002). In embryonic mouse
mutants lacking such nerves, the primitive capillary plexus
forms normally but arterial differentiation fails to occur.
Moreover, in mutants where the pattern of nerve branching is
disrupted, the arterial branching pattern still follows the
trajectory of the disorganized nerves. Thus, in limb skin, the
pattern of peripheral nerve branching provides a template that
instructively guides the branching of the emerging arterial
vascular network.
These observations raised the question of the nature of the
signal(s) that control nerve-vessel alignment and arterial
differentiation, and their cellular source(s). In culture, VEGF-
related factors derived from sensory neurons or Schwann cells
can induce arterial differentiation in endothelial cell (EC)
precursors (Mukouyama et al., 2002). These studies, however,
left unresolved the issue of whether nerve-derived VEGFA is
actually required for arterial differentiation in the limb skin in
vivo. Furthermore, the lack of an in vitro assay for nerve-vessel
alignment made it unclear whether VEGF, or rather some other
molecule, is involved in this patterning process.
Two recent studies have provided evidence of a role for
VEGFA in promoting arterial differentiation in vivo. In the
zebrafish, Vegf is essential for formation of the dorsal aorta, the
major midline arterial vessel (Lawson et al., 2002). However,
this vessel develops by de novo assembly of angioblasts, rather
than by remodeling of a capillary network. Therefore, these
data do not address whether Vegf is required to induce arterial
differentiation from a pre-existing capillary plexus, the
mechanism by which most small arterial vessels form in higher
vertebrates. In mice, transgenic overexpression of Vegfa in the
heart promoted an increased number of cardiac arterial vessels
(Visconti et al., 2002). Although these gain-of-function data
suggest that VEGFA can promote or enhance arteriogenesis in
vivo, they did not address whether it is actually required for
this process during normal development.
The early embryonic lethality of Vegfa mutants has made it
difficult to address whether nerve-derived VEGFA is required
for nerve-vessel alignment and arterial differentiation in vivo
(Carmeliet et al., 1996; Ferrara et al., 1996). To circumvent this
problem, we have now used several different lines of transgenic
mice expressing Cre recombinase, singly or in combination, to
specifically delete Vegfa in the major cell types comprising
In developing limb skin, peripheral nerves are required for
arterial differentiation, and guide the pattern of arterial
branching. In vitro experiments suggest that nerve-derived
VEGF may be important for arteriogenesis, but its role in
vivo remains unclear. Using a series of nerve-specific Cre
lines, we show that VEGF derived from sensory neurons,
motoneurons and/or Schwann cells is required for
arteriogenesis in vivo. Arteriogenesis also requires
endothelial expression of NRP1, an artery-specific co-
receptor for VEGF164 that is itself induced by VEGF. Our
results provide the first evidence that VEGF is necessary
for arteriogenesis from a primitive capillary plexus in vivo,
and show that in limb skin the nerve is indeed the principal
source of this signal. They also suggest a model in which
a ‘winner-takes-all’ competition for VEGF may control
arterial differentiation, with the outcome biased by a
VEGF164-NRP1 positive-feedback loop. Our results also
demonstrate that nerve-vessel alignment is a necessary, but
not sufficient, condition for nerve-induced arteriogenesis.
Different mechanisms therefore probably underlie these
endothelial patterning and differentiation processes.
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peripheral nerve. In parallel, we have examined the role of
neuropilin 1 (NRP1), a co-receptor for VEGF164 that is
specifically expressed in arteries. Our data indicate that nerve-
derived VEGFA is indeed required for arterial differentiation
in vivo, and further suggest that arteriogenesis may be
promoted by an NRP1-mediated positive feedback loop.
Surprisingly, nerve-vessel alignment occurs normally in these
conditional mutants, despite the defect in arteriogenesis. This
suggests that such alignment is mediated either by a residual
low level of VEGFA, or by a distinct nerve-derived signal.
Materials and methods
Experimental animals and generation of nerve-Vegf-A
conditional and endothelial Nrp1 mutants
The characterization of Vegf floxed mice (Gerber et al., 1999), Nrp1
floxed mice (Gu et al., 2003), Wnt1-Cre mice (Danielian et al., 1998),
Isl1-Cre mice (Srinivas et al., 2001; Yang et al., 2001), Tie2-Cre mice
(Gu et al., 2003; Kisanuki et al., 2001), HB9-eGFP mice (Wichterle
et al., 2002) and R26R mice (Soriano, 1999) have been reported
elsewhere. Wnt1-Cre; Isl1-Cre; Vegf flox/flox, Wnt1-Cre;Vegf flox/flox or
Isl1-Cre;Vegf flox/flox embryos were produced by mating Wnt1-Cre;
Vegf flox/+ with Isl1-Cre; Vegf flox/+ mice. Offspring were genotyped by
PCR using primers that specifically detect the transgene for Wnt1-Cre
or Isl1-Cre and the floxed Vegf allele (see ‘recombination assay by
genomic PCR’). Tie2-Cre;Nrp1flox/– embryos were produced by
mating Nrp1flox/– (harboring one floxed allele and one Nrp1 null allele)
with Tie-2-Cre; Nrp1flox/+ mice.
Genomic PCR
Cre-mediated recombination was assayed using genomic DNA
essentially as described (Inoue et al., 2002). Ten dorsal root ganglia
were isolated from one E15.5 embryo and dissociated with Proteinase
K (Sigma). Skin from both limbs was isolated from one E15.5
embryo, and dissociated by digestion with type 3 collagenase
(Worthington) and dispase (Gibco BRL). The cells were incubated
with rat anti-mouse P75 monoclonal antibody (M. Rao and D.J.A.,
unpublished) and then goat anti-rat IgG magnetic beads (Dynal). The
magnet-selected P75+ cells were dissociated with Proteinase K.
Genomic DNA was extracted and analyzed for recombination by
genomic PCR. using expand Taq DNA polymerase (Roche) for 45
cycles. The PCR products were fractionated by electrophoresis.
The sequences of the PCR primers are: VEGF419F (5′-CCT-
GGCCCTCAAGTACACCTT-3′) and VEGFc5R2 (5′-ACATCTGC-
TGTGCTGTAGGAAG-3′). For genotyping, genomic DNA was
isolated from embryonic tail tissue and the presence of Cre transgenes
was detected by PCR using PLATINUM Taq DNA polymerase
(GibcoBRL) for 28 cycles. The sequence of the PCR primers
were VEGF419F (5′-CCTGGCCCTCAAGTACACCTT-3′) and
VEGF567R (5′-TCCGTACGACGCATTTCTAG-3′) for floxed Vegf
allele; Cre5′a (5′-ACCTTCCTCTTCTTCTTGGG-3′) and Wnt1s (5′-
TAAGAGGCCTATAAGAGGCG-3′) for Wnt1-Cre transgene; IRES-
N (5′-GCAAGGTCTGTTGAATGTCGTTGA-3′) and IRES-C (5′-
GTACCTTCTGGGCATCCTTCAGC-3′) for Isl1-Cre transgene; and
Cre1 (5′-GTTCGCAAGAACCTGATGGACA-3′) Cre2 (5′-CTAG-
AGCCTGTTTTGCACGTTC-3′) for Cre transgene.
Immunohistochemistry
Staining was performed essentially as described previously
(Mukouyama et al., 2002). Embryos or limb skin tissue was fixed
with 4% paraformaldehyde/PBS at 4°C overnight, sunk in 30%
sucrose/PBS at 4°C and then embedded in OCT compound for
frozen sectioning (15 µm). Staining was performed using anti-β-
galactosidase antibodies (rabbit polyclonal antibody, 5-prime 3-prime,
1:1000, overnight at 4°C or goat polyclonal antibody, Bio Trend,
1:1000, overnight at 4°C) to detect lacZ expression; anti-GFP
antibody (rabbit polyclonal antibody, Molecular Probes; 1:500,
overnight at 4°C); anti-BFABP antibody (rabbit polyclonal antibody,
T. Müller, 1:1000, 3 hours at room temperature) to detect glial cells;
Alexa green-conjugated HuD antibody (mouse monoclonal antibody,
clone 16A11, Molecular Probe; 1:50, 1 hour at room temperature);
anti-neuronal class III β-tubulin antibody (mouse monoclonal
antibody, clone Tuj1, Covance, 1:500, 1 hour at room temperature) to
detect neurons; anti-PECAM-1 antibody (rat monoclonal antibody,
clone MEC 13.3, BD Pharmingen, 1:300, overnight at 4°C) to detect
endothelial cells; Cy3-conjugated anti-αSMA antibody (mouse
monoclonal antibody, clone 1A4, Sigma, 1:500, 1 hour at room
temperature) to detect smooth muscle cells; and anti-VEGF antibody
(goat polyclonal antibody, R&D, 1:200, overnight at 4°C). For
immunofluorescent detection, FITC-, Cy3-, Alexa-488-, Alexa-568-,
or Cy5-conjugated secondary antibodies (Jackson, 1:300, Southern
Biotechnology Associations, 1:300, and Molecular Probes, 1:250, 1
hour at room temperature) were used. All confocal microscopy was
carried out on a Leica SP confocal (Leica).
Whole-mount immunohistochemical staining of limb skin was
performed as described previously (Mukouyama et al., 2002).
Embryos at E15.5 were dissected, fixed overnight in 4%
paraformaldehyde/PBS at 4°C, and dehydrated in 100% methanol at
–20°C. Staining was performed using anti-PECAM-1 antibody to
detect endothelial cells; anti-β-galactosidase antibody to detect lacZ
expression; anti-NRP1 antibody (rabbit polyclonal antibody, A.L.
Kolodkin, 1:3000, 3 hours at room temperature); and anti-CX40
antibody (rabbit polyclonal antibody, Alpha Diagnostic International,
1:300, overnight at 4°C) as arterial markers; Cy3-conjugated anti-
αSMA antibody to detect smooth muscle cells; anti-neurofilament
antibody (mouse monoclonal antibody, clone 2H3, Developmental
Studies Hybridoma Bank, 1:200, 1 hour at room temperature); anti-
peripherin antibody (rabbit polyclonal antibody, Chemicon, 1:1000, 1
hour at room temperature) to detect nerve fibers; anti-BFABP
antibody to detect Schwann cells; and anti-VEGF antibody. FITC-,
Cy3-, Alexa-488-, Alexa-568- or Cy5-conjugated secondary
antibodies were from Jackson, Southern Biotechnology Associations
and Molecular Probes. TUNEL labeling was performed according to
the manufacturer’s protocol (In Situ Cell Death Detection, Roche).
The average mean fluorescence (pixels/area) was analyzed using
ImageJ software, and statistical significance of samples (n>3) was
assessed using Student’s t-test.
Whole-mount in situ hybridization of limb skin
Whole-mount in situ hybridization was carried out essentially as
described previously (Mukouyama et al., 2002; Wang et al., 1998).
E15.5 limbs were hybridized with a cRNA probe against the ephrin
B2 (Efnb2 – Mouse Genome Informatics) extracellular domain.
Flow cytometry and culture methods
The isolation and culture of ephrin B2-negative endothelial cells from
E10.5 Efnb2lacZ/+ embryos was performed as described previously
(Mukouyama et al., 2002). All sorts and analyses were performed on
a FACS Vantage dual laser flow cytometer (BD Biosciences). The
culture medium contained EMB-2 (Clonetics) with 15% FBS
(Hyclone Laboratories), Penicillin/Streptomycin (BioWhittaker) and
10 ng/ml bFGF (R&D). The freshly isolated endothelial cells were
challenged with serial dilutions (1-100 pg/ml) of VEGF120 or
VEGF164 isoforms (R&D), used at equal mass/volume concentrations
according to the manufacturer’s technical specifications. Cultures
were incubated for 2 days in a reduced oxygen environment to more
closely approximate physiological oxygen levels (Mukouyama et al.,
2002; Studer et al., 2000). X-gal staining and immunohistochemistry
on these cultures were performed as described (Mukouyama et al.,
2002).
The ephrin B2-lacZ-positive or negative cells were counted in
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PECAM1-positive cells and statistical significance was assessed using
the Student’s t-test.
Results
Peripheral nerve-specific deletion of Vegfa requires
Cre-mediated recombination in three different cell
types
To test directly whether peripheral nerve-derived VEGFA is
required for arteriogenesis of nerve-associated vessels in vivo,
we sought to conditionally knock out Vegfa, specifically in
these neural elements. At the stages of development
investigated (E13.5-E15.5), peripheral nerves are comprised of
Schwann (glial) cells and sensory, but not autonomic, axons
(Mukouyama et al., 2002). We have previously shown that both
Schwann cells and sensory neurons express mRNAs for
various VEGF isoforms, in vivo (Mukouyama et al., 2002). As
both of these cell types
are neural crest-derived,
deletion of Vegfa in them
can be accomplished by
employing a Wnt1-Cre
driver, which is active in
the pre-migratory neural
crest (Danielian et al.,
1998). We confirmed
deletion in both sensory
neurons and peripheral
glia by Wnt1-Cre, using
the Rosa26 Cre-
dependent lacZ reporter
(R26R) line (Soriano,
1999) (Fig. 1A,G,I,K).
Wnt1-Cre does not delete in motoneurons (Fig. 1I, open
arrow). However, motor axons are present in the peripheral
nerves innervating limb skin at E14.5, as revealed by an
enhanced green fluorescent protein (eGFP) reporter driven by
the motoneuron-specific HB9 promoter (see Fig. S1A-E,
arrows, in the supplementary material) (Wichterle et al., 2002).
To determine whether such motor axons might be an additional
source of VEGFA, we carried out an RT-PCR analysis of Vegfa
mRNA expression on EGFP+ motor neurons isolated by
fluorescence-activated cell sorting (FACS), from the spinal
cord of Hb9::EGFP embryos. This analysis revealed that
motor neurons do express mRNAs for all isoforms of VEGFA
(see Fig. S1F in the supplementary material). These data
therefore indicated that elimination of all nerve-derived
sources of Vegfa in the limb skin should require deletion of the
gene in Schwann cells, sensory and motoneurons.
As there is no single promoter-driven Cre line that
Fig. 1. Activity of Wnt1-Cre
or Isl1-Cre in peripheral
nerves. The spinal cord and
dorsal root ganglia (DRG) of
E14.5 Rosa26 Cre-
dependent lacZ reporter
(R26R) line with Wnt1-Cre
(A,C,E,G,I) or Isl1-Cre
transgene (B,D,F,H,J) are
shown. Triple
immunofluorescence
confocal microscopy with
antibodies to β-galactosidase
(β-gal) (red), the glial
marker BFABP (blue) and
the neuronal marker HuD
(green) is shown. Open
arrowheads indicate DRG
and open arrows indicate
motoneurons in the spinal
cord. White arrows indicate
Cre activation in
motoneurons. Insets are
higher-magnification details
of the DRG. Scale bar: 100
µm. (K) Schematic
illustrating peripheral nerve-
specific Cre activation
(blue). 
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simultaneously and specifically targets all three of these cell
types, we combined the Wnt1-Cre driver with an Isl1-Cre
driver, which is active in both sensory and motoneurons, but
not in Schwann cells (T. M. Jessell, unpublished) (Srinivas et
al., 2001; Yang et al., 2001). Analysis of Isl1-Cre; R26R
embryos using cell type-specific markers confirmed that this
Cre driver deletes in both sensory and motoneurons, but not in
Schwann cells (Fig. 1B; Fig. 1H, inset; Fig. 1J,K). Thus, the
combination of Wnt1-Cre and Isl1-Cre should suffice to delete
the conditional Vegfa allele (Vegf flox) in sensory neurons,
motoneurons and Schwann cells (Fig. 1K; see Fig. S2 in the
supplementary material).
Peripheral nerve-derived VEGFA is required for
proper arteriogenesis in the limb skin
To create embryos carrying both the Wnt1-Cre and Isl1-Cre
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Fig. 2. VEGFA is
required for arterial
differentiation in limb
skin. (A-F,H-M) triple
immunofluorescence
confocal microscopy
using antibodies to
either NRP1 (A-F,
red, arrows and
arrowhead) or CX40
(H-M, red, arrows and
arrowhead), together
with antibodies to
PECAM1 (A-C,H-J,
blue) and
neurofilament (2H3)
(A-C,H-J, green, open
arrowheads).
Arrowheads indicate
large-diameter
vessels.
(G,N) Quantitative
analysis of arterial
marker expression in
small-diameter
vessels. Asterisks
indicate statistically
significant differences
(P<0.05) in Vegf flox/flox
or Wnt1-Cre;
Vegf flox/flox compared
with Wnt1-Cre; Isl1-
Cre; Vegf flox/flox
(Student’s t-test).
(O-T) Whole-mount
double labeling with
TUNEL (O-T, red,
arrows) and PECAM1
(O-Q, blue) reveals
that no significant
increase in apoptosis
in the absence of
nerve-VEGFA ,
confirmed by
quantitative analysis
(U). Scale bars:
100µm.
D
ev
el
op
m
en
t
945Arteriogenesis by peripheral nerve-derived VEGF
transgenes, as well as both ‘floxed’ alleles of the Vegf gene
(Gerber et al., 1999), we generated and then inter-crossed
Wnt1-Cre; Vegf flox/+ with Isl1-Cre; Vegf flox/+ mice. On
average, one in 16 embryos derived from this inter-cross
inherited both the Wnt1-Cre and Isl1-Cre transgenes, as well
as both Vegf alleles (Vegf flox/flox). The limb skin of such
embryos was subjected to whole-mount analysis of the
expression of three independent arterial markers: neuropilin 1
(NRP1), connexin 40 (CX40; GJA5 – Mouse Genome
Informatics) and ephrin B2. The expression of all three
markers was greatly reduced in small-diameter vessels of
embryos of this genotype (Fig. 2D,F,G,K,M, arrows; Fig. 2N;
data not shown). The expression of smooth muscle markers
was also reduced, albeit to a lesser extent than that of the
arterial endothelial markers, in such embryos (data not
shown). Embryos carrying either of the individual Cre
transgenes also showed a clear, but less extensive, reduction
of arterial marker expression (Wnt1-Cre; Fig. 2E,G,L, arrows;
Fig. 2N); this was particularly evident for Isl1-Cre (data not
shown). TUNEL-labeling experiments indicated that the
reduction of arterial marker expression does not reflect a
selective death of arterial endothelial cells in these Vegf
conditional knockout embryos (Fig. 2O-U).
In contrast to the defective arterial differentiation of smaller-
diameter vessels, the expression of NRP1 and ephrin B2 was
relatively unaffected in the major, large-diameter
vessels in the skin (Fig. 2D-F; arrowheads; data not
shown). These data are consistent with our
previous observation that expression of these
arterial markers is not diminished in the large-
diameter limb vessels of mutants lacking
peripheral nerve fibers or Schwann cells
(Mukouyama et al., 2002). Similarly, no reduction
in the expression of arterial markers in other large-
diameter vessels, such as the carotid and thoracic
arteries, was observed in the mutants (see Fig. S3
in the supplementary material).
These data suggested that the arterial
differentiation of small-diameter nerve-associated
vessels, but not of large-diameter vessels, is
compromised in Wnt1-Cre; Isl1-Cre; Vegf flox/flox
embryos. One possible explanation for this
dissociation is that autocrine or paracrine secretion
of VEGFA by endothelial or smooth muscle cells
in large-diameter vessels may compensate for the
absence of nerve-derived VEGFA. In support of
this, antibody staining revealed that VEGFA is
expressed in both endothelial and smooth muscle
cells of large-diameter blood vessels (see Fig. S4E-
H in the supplementary material, arrows).
Furthermore, expression of mRNA for VEGF164
was detected by RT-PCR in endothelial cells that
were freshly isolated from E15.5 limb skin (data
not shown).
The foregoing data suggested that nerve-
derived VEGF is selectively required for
arteriogenesis in small-diameter nerve-associated
blood vessels within limb skin. To determine
whether other aspects of neuro-vascularization
might also depend on peripheral-nerve-derived
VEGF, we examined blood vessel development in
the dorsal root sensory ganglia (DRG) of the Vegfa conditional
mutants. In control (Vegf flox/flox) embryos, blood vessels both
surround the DRG (Fig. 3C, open arrowhead) and branch into
it (Fig. 3C, arrow). By contrast, there was virtually a complete
failure of such internal ganglionic vascular branching in the
DRG of Wnt1-Cre; Isl1-Cre; Vegf lox/lox or Wnt1-cre; Vegf lox/lox
embryos (Fig. 3B,D,G; data not shown), while the vessels
peripheral to the ganglia appeared unaffected (Fig. 3C,D; open
arrowheads). These data suggest that VEGFA derived from
sensory neurons and/or glia is required for proper
vascularization of the DRG, as well as for arteriogenesis in
limb skin.
Nerve-blood vessel alignment occurs normally in
the absence of nerve-derived VEGFA
In addition to their requirement for arterial differentiation,
peripheral nerves instructively guide the pattern of arterial
branching in limb skin (Mukouyama et al., 2002). Surprisingly,
in contrast to the clear defects in arterial marker expression, no
evident perturbation of nerve-blood vessel association was
observed in the nerve-derived Vegfa conditional mutants (Fig.
4A-I; data not shown). The extent of innervation of the skin,
and the coverage of nerves by Schwann cells (detected by
expression of BFABP), also appeared to be normal in the
mutants (Fig. 4E-H).
Fig. 3. VEGFA is required for normal DRG vascularization. (A-F) Double
immunofluoresence confocal microscopy of E15.5 trunk sections performed using
antibodies to PECAM1 (A-D, blue) and HuD (A,B,E,F, green). (G) Quantification
of length of PECAM1+ vascular branching in DRG. The internal vascularization of
the DRG (C, arrow) is disrupted in the nerve-Vegfa conditional mutants (D), while
vessels peripheral to the DRG appeared unaffected (C,D, arrowheads). Asterisk
indicates a statistically significant difference (P<0.05) in Vegf flox/flox compared with
Wnt1-Cre; Isl1-Cre; Vegf flox/flox (Student’s t-test). Scale bar: 100 µm.
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Verification of peripheral nerve-specific Vegfa
deletion
The foregoing experiments indicated that conditional
inactivation of Vegfa in peripheral nerve caused a failure of
arterial differentiation, but not of nerve-vessel alignment. To
examine directly the extent of VEGF reduction in the
conditional mutants, Cre-dependent excision of exon3 of the
floxed Vegf allele was first examined by genomic PCR in both
the DRG (Fig. 5J) and limb skin (data not shown). This
analysis revealed a high degree of recombination in DRG
from Wnt1-Cre, Isl1-Cre; VEGFflox/flox embryos (non-
recombined:recombined=30%:70%).
The residual non-recombined Vegf flox DNA (Fig. 5J, upper
band) may reflect incomplete excision by Cre recombinase
in cell types expressing Wnt1-Cre and Isl1-Cre, or else
contaminating non-neural cells (fibroblasts, endothelial cells,
smooth muscle cells, etc.) that do not express these Cre drivers.
To distinguish these alternatives, we analyzed the level of
VEGFA protein expression in such embryos by anti-VEGF
antibody staining (Fig. 5A-I). Anti-VEGFA immunoreactivity
was detected in both the DRG and spinal cord of control
Vegf flox/flox embryos (Fig. 5A, arrows and arrowheads,
respectively). Such immunoreactivity was markedly reduced in
both the DRG and spinal cord of Wnt1-Cre;Isl1-Cre;
Vegf flox/flox embryos (Fig. 5C,I; arrows and arrowheads),
although a few DRG cells still exhibited staining (Fig. 5C,I;
open arrows). Quantification, by measurement of fluorescent
pixel intensity per unit area, indicated an approximately
threefold reduction in staining levels in the mutant embryos
(Fig. 5I). A similar analysis in limb skin revealed a strong
reduction of VEGFA expression in peripheral nerves of
embryos harboring both Cre drivers (data not shown). Other
sites of VEGF expression, where Wnt1-Cre and Isl1-Cre are
not active, were unaffected. Taken together, these DNA- and
protein-level analyses validated the peripheral nerve-specific
deficiency of VEGFA. However, there appeared to be a residual
level of VEGFA in these neural tissues, despite the use of two
different Cre drivers with overlapping cellular specificities.
This may reflect the requirement for both Vegf flox alleles to
undergo recombination in each cell, in order to achieve
reduction to homozygosity.
Disruption of arteriogenesis, but not nerve-vessel
alignment, by endothelial-specific deletion of the
VEGF164 co-receptor NRP1
The residual low level of VEGFA in the peripheral nerves of
our conditional knockout embryos left open the possibility that
such levels were sufficient for the persistence of nerve-vessel
alignment in these mutants. To address this issue by an
independent approach, we sought to selectively reduce the
VEGF sensitivity of endothelial cells. Because deletion of the
core VEGFA receptor FLK1 (VEGFR2) in endothelial cells
would be expected to compromise their viability (M.
Hirashima and J. Rossant, personal communication), we
examined embryos with an endothelial cell-specific deletion of
the VEGF164 co-receptor NRP1 (Kawasaki et al., 1999; Soker
et al., 1998).
Such a deletion was achieved by using the endothelial-
specific Tie2-promoter to drive Cre expression in a genetic
background containing a floxed allele of Nrp1 over a
conventional null allele (Gu et al., 2003). In Tie2-Cre;
Nrp1flox/– embryos, expression of arterial markers, including
CX40 and ephrin B2, was strongly reduced in limb vessels
(compare Fig. 6C with 6D, arrows; Fig. 6E; data not shown).
Surprisingly, in these mutants even the large-diameter vessels
exhibited a strong reduction of arterial marker expression, as
Development 132 (5) Research article
Fig. 4. Nerve-blood vessel alignment is
unaffected in the absence of nerve-derived
VEGFA. (A-H) Whole-mount triple
immunofluorescence confocal microscopy
using antibodies to BFABP (A-H, red),
PECAM1 (A-H, blue) and neurofilament
(2H3) (A-D, green) is shown. Close-up
images (C,D,G,H) show the boxed regions in
A,B,E,F. Arrows indicate blood vessels,
arrowheads the aligned nerves and open
arrowheads Schwann cells. Scale bars: 100
µm. (I) The alignment of nerves with blood
vessels was quantified as the percentage of
nerve length aligned with vessels.
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well as in smooth muscle coverage (compare Fig. 6C with 6D;
compare Fig. 6H with 6I, arrowheads). The defects in limb skin
arterial differentiation observed in mutants lacking endothelial
NRP1 were, therefore, similar but even more pronounced than
those observed in embryos deficient in peripheral nerve-
derived VEGFA. Despite this more severe failure of
arteriogenesis in limb skin, the association of nerves with blood
vessels appeared normal in Tie2-Cre; Nrp1flox/– embryos (Fig.
6B,G, compare arrows with open arrowheads).
NRP1 binding isoforms of VEGFA preferentially
induce arterial markers in vitro
The requirement of Nrp1 for arteriogenesis in vivo is
surprising, given that NRP1 is a co-receptor for only the
VEGF164 isoform, and that peripheral nerve elements express
mRNAs for multiple VEGF isoforms (Mukouyama et al.,
2002) (see Fig. S1F in the supplementary material). This
observation raised the issue of whether VEGF164 is more potent
than other VEGFA isoforms in its ability to induce arterial
marker expression in undifferentiated endothelial cells. To
address this, we compared the ability of VEGF164 and a non-
NRP1-binding isoform, VEGF120, to induce arterial marker
expression in vitro. We employed a previously described
system in which PECAM1+,
β-gal– embryonic endothelial
cells are isolated by flow
cytometry from Efnb2lacZ/+
knock-in mice and cultured
in bFGF (Mukouyama et
al., 2002). Under these
conditions, the effects of
VEGF in inducing arterial
marker expression can be
examined in the absence of
any confounding effects on
cell survival.
In such cultures, both
VEGF164 and VEGF120
induced expression of Efnb2-
lacZ (Fig. 7A-F). At 100
pg/ml, both isoforms induced
ephrin B2 expression to a
similar extent (Fig. 7M, left
panel). However, at lower concentrations (1-10 pg/ml),
VEGF164 was at least twice as effective as VEGF120 at inducing
ephrin B2-lacZ expression (Fig. 7M, green bars). There was no
effect on cell survival at any of the concentrations tested, for
both isoforms (Fig. 7M, right panel). These data suggest that
NRP1-binding isoforms of VEGF may preferentially promote
arterial differentiation, in comparison with non-NRP1-binding
isoforms, at very low concentrations of the growth factor.
We have shown that the artery-specific expression of NRP1
is dependent on nerve-derived VEGFA in vivo (Fig. 2E-G).
Moreover, NRP1 itself is required in endothelial cells for
arterial differentiation (Fig. 6D), and an NRP1-binding isoform
of VEGF preferentially upregulates the arterial marker ephrin
B2 in vitro. These data suggest that a positive-feedback loop
involving NRP1 and VEGF may contribute to arteriogenesis.
To address more directly this possibility, we examined the
ability of VEGFA isoforms to upregulate NRP1 expression in
vitro. Both VEGF120 and VEGF164 upregulated expression of
NRP1 in cultured embryonic endothelial cells (Fig. 7G-L). The
proportion of NRP1+ cells was similar to that of ephrin B2+
cells, in the presence of either VEGF isoform, although direct
double-labeling for both markers was precluded by antibody
incompatibility. These data demonstrate that NRP1-binding
Fig. 5. Reduction of VEGFA expression by
Cre-mediated recombination. (A-H) Triple
immunofluorescence confocal microscopy
using antibodies to VEGF (A,B,E,F, red), HuD
(C-F, green) and BFABP (G,H, blue). Arrows
indicate DRG; arrowheads indicate spinal
cord. (I) Quantification of anti-VEGFA
immunoreactivity in DRG in embryos of
various genotypes. There was no consistent
alteration in either HuD+ neuronal (C,D) or
BFABP+ glial (G,H) development in multiple
specimens. Scale bars: 100 µm. (J) The
efficient deletion of the floxed Vegf allele was
determined by PCR analysis of DRG. The
PCR product of the recombined allele is
smaller than that of the non-recombined allele.
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VEGFA isoforms can upregulate the expression of NRP1 itself,
as well as that of other arterial-specific markers, in embryonic
endothelial cells.
Discussion
In this study, we have used a conditional gene inactivation
approach to investigate the signaling systems that control
nerve-dependent arteriogenesis and blood vessel patterning in
developing limb skin. Our data provide the first in vivo
evidence that VEGF, which is derived from local tissue
sources, is required to induce arteriogenesis during angiogenic
remodeling of a primitive capillary network. The results also
imply an important role for the heparin-binding isoform of
VEGF in arterial differentiation in vivo. Consistent with this,
we provide evidence that the NRP1-binding isoform
of VEGF is a more potent inducer of arterial markers
in vitro, compared with other VEGF isoforms. These
data suggest a model in which a ‘winner-takes-all’
competition for VEGF may control arterial
differentiation, with the outcome biased by a
VEGF164-NRP1 positive-feedback loop. The
requirement for NRP1 may also help to explain how
arteriogenesis is restricted to those vessels located in
close proximity to the nerve.
Despite their profound effects on arterial
differentiation, neither the Vegfa nor the Nrp1
conditional mutants disrupted nerve-vessel alignment.
This genetic uncoupling of arteriogenesis and nerve-
vessel association suggests that guidance of the vessel
branching pattern by the nerve requires either a very
low concentration of VEGF, or more likely a second,
as yet unidentified, signaling system (Fig. 8A).
Peripheral nerve-derived VEGFA is required
for arteriogenesis in the limb skin
vasculature in vivo
Previous studies have indicated that VEGF is
required for de novo differentiation of the dorsal
aorta in zebrafish (Lawson et al., 2002), and is
sufficient to increase the density of cardiac arterial
vessels when overexpressed in the heart (Visconti et
al., 2002). However, these experiments did not
address whether VEGF is required for arterial
differentiation from a pre-existing capillary network,
during normal development in vivo. The present
results indicate that nerve-derived VEGFA is
required for arteriogenesis in the primitive capillary
plexus of murine limb skin. These data provide
additional evidence that VEGF functions as an
arterial-inducing signal in vivo, in addition to its
classical role as a growth and survival factor for
endothelial cells (Ferrara, 2000). Interestingly, the
degree of arterial differentiation in the nerve-specific
Vegfa mutants depended upon the extent of Vegfa
deletion (as observed in different Wnt1- or Isl1-Cre-
containing genotypes; Fig. 2). This suggests a dose-
sensitive requirement for VEGFA in nerve-
dependent arteriogenesis, consistent with our in vitro
observations (Mukouyama et al., 2002).
Recent data have demonstrated that the endothelial
specific Notch ligand Delta-like 4 (Dll4) is essential for
arteriogenesis in vivo (Duarte et al., 2004; Gale et al., 2004;
Krebs et al., 2004). Studies in zebrafish have suggested that
dorsal aorta formation is controlled by VEGF and Notch
signaling, acting in series (Lawson et al., 2001; Lawson et al.,
2002). In preliminary experiments, we have found that arterial
markers are induced in cultured murine embryonic endothelial
precursor cells not only by VEGF, as previously reported
(Mukouyama et al., 2002), but also by soluble Notch ligands.
Interestingly, the ability of VEGF to induce arterial marker
expression is blocked by peptide inhibitors of Notch activation,
while a soluble VEGF receptor antagonist does not block
induction of such markers by Notch ligands (Y.M. and D.J.A.,
unpublished). These data suggest that in mouse, as in zebrafish,
VEGF induces arterial differentiation by acting through the
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Fig. 6. NRP1 is required for arteriogenesis in limb skin. Analysis of E15.5 limbs
from Tie2-Cre;Nrp1flox/– mutants or control littermates (Nrp1flox/+) is shown.
(A-D,F-I) Triple immunofluorescence confocal microscopy using antibodies to
either CX40 (A-D, red) or αSMA (F-I, red), together with anti-PECAM1
(A,B,F,G, blue) and neurofilament (2H3) (A,B,F,G, green). (E) Quantification of
CX40 expression, and (J) of αSMA+ cell coverage in small-diameter vessels.
Asterisks indicate statistically significant differences (P<0.05) in Tie2-
Cre;Nrp1flox/– compared with Nrp1flox/+ (Student’s t-test). Nerve-blood vessel
alignment in the Tie2-Cre;Nrp1flox/– mutants appears normal (C versus D, H
versus I, arrows and open arrowheads). Scale bars: 100 µm.
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Notch pathway. How the interaction between these two
signaling systems occurs is not yet clear.
What cell type(s) within peripheral nerve are the most
important source(s) of VEGFA? We observed the strongest
reduction of arterial marker expression when Vegfa was deleted
in all three neural cell types (Wnt1-Cre+Isl1-Cre), and a
weaker phenotype using either Wnt1-Cre or Isl1-Cre alone
(Fig. 2 and data not shown). One explanation for this higher
expression is that it reflects a requirement to eliminate Vegfa
expression in all three peripheral nerve cell types, as Isl1-Cre
is not expressed in Schwann cells, while Wnt1-Cre is not
expressed in motoneurons. Motoneurons are not the primary
source of VEGF in the nerve, however, as arterial marker
expression is normal in Olig1; Olig2 double mutants (Zhou and
Anderson, 2002), which lack all spinal motoneurons, but have
a normal complement of sensory neurons (Y.M., Q. Zhou and
D.J.A., unpublished). A Schwann cell-specific knockout of
Vegfa is currently not possible, because all available Cre driver
lines active in these peripheral glia, including Po-Cre (Feltri et
al., 1999; Giovannini et al., 2000), desert hedgehog (Dhh)-Cre
(Lindeboom et al., 2003) and BFABP-Cre (Anthony et al.,
2004), also promote recombination in peripheral neurons (Y.M.
and D.J.A., unpublished). This most probably reflects the early
expression of these glial promoters in multipotent neural crest
stem or progenitor cells (Kim et al., 2003).
A second explanation is that, since both Wnt1-Cre and Isl1-
Cre are expressed in sensory neurons, the stronger phenotype
of Wnt1-Cre, Isl1-Cre embryos reflects a higher level of
Cre expression in these cells, leading to more efficient
recombination at the Vegfa locus. The structure of the
conditional Vegfa allele makes it impossible to determine
whether individual sensory neurons have undergone Cre-
mediated recombination in one or both alleles. However, the
reduction of VEGFA immunoreactivity in the DRG appeared
greater in Wnt1-Cre; Isl1-Cre mutants than in Wnt1-Cre
mutants (data not shown), suggesting a more efficient
recombination with both Cre drivers.
NRP1 is important for arteriogenesis
An endothelial-specific knockout of Nrp1 produced an even
more severe defect in arteriogenesis than was observed in the
nerve-specific Vegfa conditional knockouts. There are several
possible explanations for this difference. First, cardiac defects
in the endothelial Nrp1 mutants (Gu et al., 2003) might affect
peripheral arteriogenesis via impaired blood flow; by contrast
cardiac development in the nerve-Vegfa mutants appears to be
normal. We think this is unlikely, because dorsal aorta
arteriogenesis is normal in conventional Nrp1-null mice (Y.M.,
D.J.A. and H. Fujisawa, unpublished). Second, the Tie2-Cre;
Nrp1 phenotype could reflect a requirement for a ligand of
NRP1 other than VEGF164, such as a semaphorin. In avian
embryos, implantation of Sema3a protein or of a neutralizing
anti-Sema3a antibody, caused a failure of proper
vascularization (Bates et al., 2003). Others have reported
angiogenesis defects in Sema3a mutant mice on a CD-1 genetic
background (Serini et al., 2003). However, we observed no
defects in limb skin arteriogenesis in Sema3a-null mice
(Taniguchi et al., 1997), on the C57Bl6 background used here
(Mukouyama et al., 2002). Third, the stronger arteriogenesis
defects in Tie2-Cre; Nrp1 embryonic limb skin vasculature
may reflect a more complete interruption of VEGF signaling
Fig. 7. NRP1 expression and arterial induction by VEGF164 in vitro.
(A-L) PECAM1+, ephrin B2-β-gal– embryonic endothelial cells
isolated by flow cytometry from Efnb2lacZ/+ knock-in embryos were
cultured in 100 pg/ml of VEGF120 or VEGF164 plus 10 ng/ml bFGF
for 2 days, and double-labeled with antibodies to either β-gal (A-F,
red) or NRP1 (G-L, red) together with PECAM1 (A-C,G-I, green).
Scale bars: 100 µm. (M) Preferential induction of ephrin B2 by
VEGF164. Cells as in A-L were cultured in the indicated
concentrations of VEGF120 or VEGF164 for 2 days, followed by
double-labeling with anti-PECAM and X-gal. Both the percentage of
ECs expressing ephrin B2-lacZ (left) and the total number of ECs
(right) were determined. The concentrations of VEGF120 were 1.4-
fold higher, on a molar basis, then the concentration of VEGF164
used at each serial dilution. Bars represent mean±s.e.m. Asterisks
indicate statistically significant differences (P<0.05) between
VEGF164 and VEGF120 (Student’s t-test). 
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than is obtained in Wnt1-Cre; Isl1-Cre; Vegf flox/flox embryos.
This could occur either because deletion of a crucial co-
receptor in endothelial cells reduces responsiveness to
VEGF164 derived from all local tissue sources, neural or
otherwise, and/or because Cre-mediated recombination of
Nrp1 is required in only one allele to achieve reduction to
homozygosity, whereas recombination of both Vegf flox alleles
is required.
What might be the function(s) of NRP1 in arteriogenesis?
Because NRP1 is arterial specific (Moyon et al., 2001;
Mukouyama et al., 2002) and is itself induced by VEGF (Y.M.,
H.-P.G., N.F. and D.J.A., unpublished) (Fig. 7) (Oh et al.,
2002), it could mediate a positive-feedback loop, that increases
the sensitivity of nascent arterial cells to VEGF. This feedback
loop could be initiated by non-NRP1-binding isoforms of
VEGF (e.g. VEGF120), which we have shown induce NRP1 in
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Nerve-vessel
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Arteriogenesis
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VEGF
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Fig. 8. Schematic models for nerve-mediated arterial differentiation and vascular branching in the limb skin. (A) Proposed sequence of events
in vascularization of limb. A low concentration of VEGFA, or a distinct nerve-derived signal (‘factor X’) promotes nerve-vessel alignment,
followed by VEGFA/NP-1-dependent arteriogenesis in nerve-aligned vessels. Modified from Cleaver and Krieg (Cleaver and Krieg, 1999). (B)
VEGF promotes arteriogenesis via an NRP1-mediated positive-feedback loop. All vessels (blue) are initially equivalent. Nerve-derived VEGFA
promotes arterial differentiation and NRP1 amplifies the VEGFA effect due to increased sensitivity to VEGF164 in vessels in close proximity to
nerves (N, green). A, artery.
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vitro, and maintained or further amplified by the NRP1-binding
isoform. These considerations suggest a model in which a
‘winner-takes-all’ competition for VEGF may control arterial
differentiation, with the outcome biased by a VEGF164-NRP1
positive-feedback loop (Fig. 8B). In addition, because NRP1 is
selective for the heparin-binding isoform of VEGF, it could
also function to restrict induction of arterial markers to those
vessels in close proximity to nerves.
This model predicts that nerve-dependent arteriogenesis
should be compromised in mice selectively lacking the NRP1-
binding isoform. But in such mice, e.g. those expressing only
VEGF120, arterial differentiation is normal in both the retina
(Stalmans et al., 2002) and developing limb (Y.M., D.J.A. and
P. Carmeliet, unpublished). The levels of VEGF120 expression
in these mutant mice, however, are similar to the combined
levels of VEGF120, VEGF164 and VEGF188 expression in wild-
type mice, i.e. almost three-fold higher than normal (Carmeliet
et al., 1999). As we have shown in vitro, at higher
concentrations (>10 pg/ml), VEGF120 is equally effective as
VEGF164 at inducing arterial differentiation. Therefore the
increased levels of VEGF120 in Vegf120/120 mice may obscure
the requirement for the VEGF164 isoform in arteriogenesis.
Such an explanation would be consistent with the fact that in
zebrafish, overexpression of either Vegf121 or Vegf165 can rescue
arterial differentiation blocked by a deficiency of Shh signaling
(Lawson et al., 2002).
Although a commercial source of both VEGF isoforms was
used according to the manufacturer’s technical specifications
(R&D), we recognize the possibility that these two
preparations might have differences in specific activity that
could account for their differential ephrin B2-inducing
activities in our assay. It is difficult to compare the activities
of these two isoforms independently of the presence of NRP1,
because both isoforms induce this co-receptor at
concentrations well below those at which they promote
survival and proliferation. However, using porcine aortic
endothelial cells, which do not express NRP1, Soker et al.
(Soker et al., 1998) demonstrated that both VEGF121 and
VEGF165 had equal activities in a chemotaxis assay when the
cells were reconstituted with exogenous VEGFR2 (Soker et al.,
1998). Furthermore the concentrations of VEGF120 used in our
assay were 1.4-fold higher, on a molar basis, than the
concentration of VEGF164 used at each serial dilution. The fact
that the latter isoform exhibited more potent ephrin B2-
inducing activity, under conditions where there was a bias in
favor of VEGF120, makes it more likely that the difference
observed is indeed intrinsic to the two isoforms.
Relationship between arteriogenesis and nerve-
vessel alignment
During normal development, arteriogenesis is immediately
preceded by nerve-vessel alignment and is dependent on the
presence of nerves (Mukouyama et al., 2002). Our results
demonstrate that it is possible to genetically uncouple these
sequential processes: in mutants that disrupt VEGF signaling
from the nerve to the vessels, arteriogenesis is disrupted, while
nerve-vessel alignment is apparently unperturbed. The simplest
explanation for this uncoupling is that a nerve-derived factor
distinct from VEGF mediates the alignment process. However,
the residual VEGF detected in the conditional Vegf knockout
embryos leaves open the possibility that nerve-vessel
alignment simply requires a lower threshold level of VEGF,
than does arteriogenesis. Nevertheless, the fact that the
arteriogenesis defect is even stronger in the endothelial-specific
Nrp1 knockout, while nerve-vessel alignment remains intact,
argues against the dual-threshold model. At the very least, for
such a model to be tenable, the Tie2-Cre; Nrp1 data would
require that alignment depend only on the non-heparin-
binding, more diffusible VEGF isoforms. This is reasonable
given that alignment presumably requires action-at-a-distance
to attract the vessels to the nerves. However, we did not see
any significant defects in nerve-vessel alignment in the limb
skin of mutants that lack the VEGF120 isoform (Y.M., D.J.A.
and P. Carmeliet, unpublished). Therefore, the available data
favor the notion that VEGF and a separate, as yet unidentified
signal, mediate arteriogenesis and nerve-vessel alignment,
respectively.
Is nerve-vessel alignment stochastic or
deterministic?
What determines which blood vessels in skin become aligned
with nerves and undergo arteriogenesis? One explanation is
that the process is stochastic: all vessels are equally capable of
becoming aligned with nerves, and the selection of a subset for
arteriogenesis is simply determined by their initial proximity
to nerves at the time of innervation. A mechanism involving a
‘winner-takes-all’ competition for limiting amounts of nerve-
derived VEGF, biased by the VEGF164-NRP1 positive-
feedback loop discussed earlier, would be well suited to such
a mechanism (Fig. 8B). Alternatively, a subset of vessels may
be pre-specified for association with the nerve. For example, if
nerves release a signal that recruits vessels to align with them,
then a subset of vessels might express higher levels of a
receptor for this alignment signal, before the nerves ever arrive.
Such a pre-specification mechanism would, however, require
precise matching to ensure a sufficient supply of presumptive
arterial vessels for developing nerves. The identification of
nerve-derived signals for vessel alignment may help to
distinguish between these alternatives.
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